Quick Answer
Nasus Pharma Ltd reported Stockholders Equity of $2.77 million for the year ending 2025.
- Nasus Pharma Ltd showed an increase of +186.2% in Stockholders Equity from 2024 to 2025.
- This data is from Nasus Pharma Ltd's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), Nasus Pharma Ltd's Stockholders Equity has grown by 199.4%.
- Historical annual values: Fiscal year 2025: $2.77 million | Fiscal year 2024: -$3.21 million | Fiscal year 2023: -$3.80 million | Fiscal year 2022: -$2.79 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: